Variant · Snv
PSMB9 NM_002800.5(PSMB9):c.517C>T (p.Arg173Cys)
CI-VAR-00242338Explore in graph →p.Arg173CysNM_002800.5:c.517C>TClinVar 1711625 rs17213861
Curated evidence
Evidence by cancer (0 items)
Grouped by cancer context first, then therapy. The same variant can be sensitizing in one cancer and irrelevant in another — contexts are never merged. 50 items per page; a cancer group may continue on the next page.
Data not yet available
No curated evidence item references this variant yet.
ClinVar
Clinical significance (1)
ClinVar interpretations are shown as structured records — significance, review status, star rating, conditions — never flattened into one word.
clinvarProvenance
- Source
- NCBI ClinVar (variant_summary)
- Dataset
- ClinVar variant_summary
- Version
- 2026-09-24
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Evidence
- database
- License
- Public domain (US Government work, NCBI/NLM); acknowledgment requested
- Run
- ING-CLINVAR-20260929-000001
| Variation | Clinical significance | Review status | Stars | Conditions | Origin | Submitters | Last evaluated | Source |
|---|---|---|---|---|---|---|---|---|
| 1711625 | Likely benign | criteria provided, multiple submitters, no conflicts | 2 | PSMB9-related disorder; Clear cell carcinoma of kidney; Familial pancreatic carcinoma; Lymphoma; Melanoma; Uterine corpus endometrial carcinoma; Uveal melanoma; Ovarian serous cystadenocarcinoma; Cholangiocarcinoma; Cervical cancer; Acute myeloid leukemia; Colon adenocarcinoma; Colorectal cancer; Hepatocellular carcinoma; Malignant tumor of esophagus; Sarcoma; Gastric cancer; Lung cancer | germline | 6 | Jan 01, 2026 | clinvar |